News

Keratin hydrogels show significant potential to regenerate lost muscle tissue and function

New Rochelle, NY, April 27, 2017—The use of human hair-derived keratin biomaterials to regenerate skeletal muscle has shown promise in new research that documents significant increases in both new muscle tissue formation and muscle function among mouse models of volumetric muscle loss. Two new studies that compare muscle regeneration following treatment with keratin hydrogels, no… Read more »


KeraNetics awarded $1M contract from the Department of Defense Small Business Innovation Research Program for keratin biomaterial system for functional tissue regeneration

Winston-Salem, N.C., August 20, 2015 – KeraNetics LLC announced today that it has been awarded a $1M Department of Defense (DoD) contract under the Small Business Innovation Research (SBIR) program for final pre-clinical testing and a safety trial of KeraGenics Muscle for the treatment of volumetric muscle loss (VML). Dr. Luke Burnett, Chief Science Officer… Read more »


KeraNetics awarded $1.4M contract from the Congressionally Directed Medical Research Program for use of KeraGenics Bone for military bone injuries

Winston-Salem, N.C., July 17, 2015 – KeraNetics LLC announced today that it has been awarded a $1.4M Congressionally Directed Medical Research Program (CDMRP) contract under the Department of Defense Joint Warfighter Medical Research Program for pre-clinical testing of KeraGenics Bone for the treatment of segmental bone defects.  Dr. Burnett, Chief Science Officer for the company… Read more »


Kim Westmoreland: Fulfilling biotech’s promise to Winston-Salem

As it gears up for human clinical trials, biotech firm KeraNetics has quadrupled its space within Wake Forest Innovation Quarter as it heads — hopefully — toward FDA approval for its products. At the helm of the firm, which is developing a keratin-based platform used to help tissue repair and heal itself, is Kim Westmoreland,… Read more »


KeraNetics awarded SBIR for KeraStat and halofuginone for burn scar treatment

Winston-Salem, N.C., February 2, 2014 – KeraNetics LLC announced today that it has been awarded a $1,000,000 SBIR Phase II contract from the US Army for testing KeraStat Burn Gel and Halofuginone for the treatment of burn scars. Dr. Luke Burnett, Chief Science Officer for the Company and Principal Investigator for the project said of… Read more »


Biotech firm KeraNetics shows off new space in Innovation Quarter

See the Winston Salem Journal article KeraNetics LLC, a Winston-Salem biotechnology company, is in the midst of a pivotal transition from focusing on research and development of therapeutic products to being a manufacturer. A major part of that shift was put on display Monday – a 9,000-square-foot facility in Wake Forest Innovation Quarter that more than… Read more »